webinar register page

Webinar: PERIO-02 CCF Patient Webinar
Steven C. Katz, M.D., FACS, chief medical officer at TriSalus Life Sciences®, is the featured speaker for this patient webinar. He leads a review of the Pressure-Enabled Regional Immuno-Oncology (PERIO™-02) clinical trial for adults with intrahepatic cholangiocarcinoma and hepatocellular carcinoma, the most common primary liver tumors. The esteemed Milind Javle, M.D., joins Katz. Javle is a professor of G.I. Medical Oncology at MD Anderson Cancer Center. Rahul Sheth, M.D., associate professor in the Department of Interventional Radiology at the MD Anderson Cancer Center, also participates as a guest.

The PERIO-02 trial evaluates SD-101, an investigational toll-like receptor 9 (TLR9) agonist, delivered intravascularly by the TriNav® Infusion System using the Pressure-Enabled Drug Delivery™ (PEDD™) method of administration. The study objective is to understand the ability of this platform to overcome two significant challenges of treatment: immune response suppression and ineffective drug delivery.

Jun 27, 2022 04:00 PM in Mountain Time (US and Canada)

Webinar logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Cholangiocarcinoma Foundation.